Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China
· Delayed Price · Currency is CNY 23.10
-0.38 (-1.62%)
Mar 10, 2026, 3:00 PM CST
SHA:600513 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,703 | 2,829 | 3,180 | 2,696 | 2,782 | 2,969 | Upgrade
|
| Market Cap Growth | 132.94% | -11.04% | 17.94% | -3.08% | -6.30% | 32.30% | Upgrade
|
| Enterprise Value | 8,311 | 3,616 | 3,816 | 3,234 | 3,159 | 3,137 | Upgrade
|
| Last Close Price | 23.48 | 9.81 | 10.85 | 9.01 | 9.15 | 9.65 | Upgrade
|
| PE Ratio | - | 33.61 | 23.55 | 19.07 | 23.41 | 28.83 | Upgrade
|
| PS Ratio | 2.58 | 1.31 | 1.46 | 1.38 | 1.69 | 2.14 | Upgrade
|
| PB Ratio | 3.86 | 1.79 | 2.10 | 1.91 | 2.17 | 2.51 | Upgrade
|
| P/TBV Ratio | 6.41 | 2.22 | 2.58 | 2.33 | 2.62 | 3.03 | Upgrade
|
| P/OCF Ratio | - | 262.77 | 19.79 | 21.13 | 20.11 | 32.30 | Upgrade
|
| EV/Sales Ratio | 3.20 | 1.67 | 1.76 | 1.65 | 1.92 | 2.26 | Upgrade
|
| EV/EBITDA Ratio | 64.34 | 19.61 | 16.19 | 13.27 | 15.83 | 17.82 | Upgrade
|
| EV/EBIT Ratio | 126.03 | 28.97 | 21.21 | 15.94 | 18.42 | 20.37 | Upgrade
|
| EV/FCF Ratio | -20.63 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.85 | 0.56 | 0.47 | 0.49 | 0.44 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 11.42 | 4.77 | 2.99 | 2.83 | 2.80 | 2.17 | Upgrade
|
| Net Debt / Equity Ratio | 0.69 | 0.42 | 0.28 | 0.25 | 0.18 | 0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | 9.40 | 3.56 | 1.80 | 1.47 | 1.14 | 0.80 | Upgrade
|
| Net Debt / FCF Ratio | -2.99 | -3.77 | -10.62 | -3.86 | -6.75 | -1.70 | Upgrade
|
| Asset Turnover | 0.73 | 0.74 | 0.78 | 0.77 | 0.75 | 0.70 | Upgrade
|
| Inventory Turnover | 3.25 | 2.91 | 3.80 | 3.79 | 3.77 | 2.97 | Upgrade
|
| Quick Ratio | 0.61 | 0.67 | 0.72 | 0.74 | 0.85 | 0.93 | Upgrade
|
| Current Ratio | 1.14 | 1.10 | 1.09 | 1.10 | 1.18 | 1.29 | Upgrade
|
| Return on Equity (ROE) | -1.74% | 6.88% | 10.33% | 12.35% | 11.36% | 10.61% | Upgrade
|
| Return on Assets (ROA) | 1.16% | 2.66% | 4.04% | 5.00% | 4.87% | 4.89% | Upgrade
|
| Return on Invested Capital (ROIC) | -9.50% | 4.88% | 8.38% | 10.88% | 10.62% | 10.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.90% | 7.40% | 11.20% | 13.80% | 12.80% | 12.60% | Upgrade
|
| Earnings Yield | -0.65% | 2.97% | 4.25% | 5.24% | 4.27% | 3.47% | Upgrade
|
| FCF Yield | -6.01% | -6.15% | -1.26% | -3.45% | -1.21% | -2.77% | Upgrade
|
| Dividend Yield | 0.38% | 0.91% | 1.38% | 1.66% | 1.37% | 1.12% | Upgrade
|
| Payout Ratio | - | 60.08% | 37.94% | 38.48% | 33.48% | 41.27% | Upgrade
|
| Buyback Yield / Dilution | -0.86% | -1.03% | 0.44% | 0.46% | -1.31% | -0.48% | Upgrade
|
| Total Shareholder Return | -0.47% | -0.12% | 1.82% | 2.13% | 0.06% | 0.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.